How will I feel after a Rituxan infusion?
After a Rituxan (rituximab) infusion you may experience certain side effects or adverse reactions that make you feel unwell. Rituxan affects different people in different ways, but the more common side effects include:
- Signs of infection: Fever (high temperature), muscle aches, headaches and chills.
- Bruising and bleeding (from low platelets): nosebleeds or bleeding gums, as well as tiny red spots on your limbs called petechiae.
- Allergic reactions: Fever, chills, nausea and vomiting, breathing difficulties and dizziness. Allergic reactions are more common during your infusion, particularly your first one and medications can help to manage your symptoms. Allergy medications can make you dizzy or drowsy, so do not drive yourself home after your infusion.
- Nausea and vomiting. You may feel sick or actually be sick because of your infusion. Anti-sickness medications, called antiemetics, can help to control your symptoms. Eating small meals and snacks, avoiding fatty and fried food, drinking plenty of water can also help.
- Skin and hair changes: You may lose your body hair, including eyelashes and eyebrows. Skin rashes, dry skin and itching are also common.
- Weakness or body fatigue, known as asthenia, and tiredness.
- Swelling
- Diarrhea
- Muscle spasms
- Depression
Rituxan is used to treat a range of conditions and how a person feels after their infusion can be affected by the condition they are being treated for.
Related questions
- What are the new drugs for rheumatoid arthritis (RA)?
- What are monoclonal antibodies?
- How long does it take for Rituxan to work?
Infusion-Related Reactions
Reactions during or shortly after infusion are common and may include:
- Itching
- Lightheadedness
- Swelling
- Difficulty breathing
- Abnormal heartbeat
The following adverse reactions are also common in particular patient groups including in patient with:
- Non-Hodgkin’s lymphoma (NHL): fever, chills, infection, weakness, infection and lymphopenia.
- Chronic lymphocytic leukemia (CLL): neutropenia.
- Rheumatoid arthritis (RA): upper respiratory tract infection, nasopharyngitis (cold symptoms), urinary tract infection and bronchitis.
- Granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA): infections, nausea, diarrhea, headache, muscle spasms, anemia and peripheral edema (swelling).
- Pemphigus vulgaris (PV): depression.
How Rituxan Works
Rituxan is a monoclonal antibody therapy that targets a protein called CD20 on certain immune cells. Rituxan is administered via an intravenous infusion, which involves administering the therapy through a needle placed in a vein in your arm.
Discuss any concerns with your healthcare provider before and after your infusion. Your healthcare provider may recommend medications to help manage side effects and monitor for any serious reactions.
References
- Food and Drug Administration (FDA). Rituxan. Highlights of Prescribing Information. [Accessed May 11, 2020]. Available online at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103705Orig1s5458lbl.pdf.
- Cancer Research UK. Rituximab (Mabthera, Rixathon, Truxima). [Accessed May 11, 2020]. Available online at: https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/cancer-drugs/drugs/rituximab.
Read next
What are biosimilar drugs and how do they compare to biologics?
A biosimilar is a biological product that is similar to a reference biologic (usually the originally approved product) and for which there are no clinically meaningful differences in terms of safety, purity, and potency. One example is Amjevita (adalimumab-atto), the first biosimilar approved for Humira (adalimumab) in 2016.
Continue reading
Does Rituxan cause hair loss?
It’s possible for Rituxan (rituximab) to cause hair loss. This includes losing hair anywhere on your body, such as your head, legs, eyebrows, and eyelashes. Hair loss (alopecia) does not seem to be a common side effect of Rituxan. Continue reading
How does the drug Rituxan work?
Rituxan (rituximab) is a monoclonal antibody that targets the CD20 protein found on the surface of B-cells, a type of white blood cell involved in immune responses. By binding to CD20, Rituxan helps eliminate these cells, which is beneficial in treating certain cancers and autoimmune disorders. Continue reading
Related medical questions
- What is the difference between Truxima and Rituxan?
- What is the success rate of Rituxan (rituximab) in patients with blood cancers?
- How do you prepare for a Rituxan infusion?
- What is the success rate of Rituxan (rituximab) in rheumatoid arthritis?
- What is the difference between Rituxan and Rituxan Hycela?
- What are biologic drugs and how do they work?
- What biosimilars have been approved in the United States?
- Are lung nodules common after Bendeka & Rituxan therapy?
Drug information
- Rituxan Information for Consumers
- Rituxan prescribing info & package insert (for Health Professionals)
- Side Effects of Rituxan (detailed)
- Rituxan user reviews (50)
Related support groups
- Rituxan (21 questions, 105 members)
- Rheumatoid Arthritis (333 questions, 1,329 members)
- Chronic Lymphocytic Leukemia (CLL) (27 questions, 57 members)
- Non-Hodgkin's Lymphoma (16 questions, 39 members)
- Granulomatosis with Polyangiitis (9 questions, 18 members)
- Microscopic polyangiitis (5 questions, 6 members)
- Pemphigus Vulgaris (4 questions, 4 members)